MyoKardia (MYOK) Files for $86.25M Common Stock IPO
Tweet
Share
E-mail
Get Alerts MYOK Hot Sheet
Join SI Premium – FREE
MyoKardia, Inc. (Nasdaq: MYOK) filed a registration for an IPO of its Common Stock. The proposed maximum offering price is $86.25 million. The company plans to list on the Nasdaq under the symbol, MYOK.
Underwriters are Credit Suisse, Cowen and Company, BMO Capital Markets, and Wedbush PacGrow.
MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Create E-mail Alert Related Categories
IPOsRelated Entities
Credit Suisse, BMO Capital, Cowen & Co, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
